Home » Topics » Disease categories and therapies » Substance use and poisoning

Substance use and poisoning
RSS

Lundbeck's Selincro approved in E.U. for alcohol dependence

March 1, 2013

MediciNova's MN-166 gets fast track designation from FDA

Feb. 26, 2013

The University of Bath designs agents for drug and alcohol abuse

Feb. 7, 2013

Novel compounds described as potential therapies for nerve agent poisoning

Feb. 4, 2013

OrbeShield granted fast track designation for gastrointestinal ARS

Jan. 30, 2013

Novartis to return NIC-002 rights to Cytos

Jan. 23, 2013

BioDelivery Sciences completes BNX safety study

Jan. 23, 2013

FDA clears IND to investigate OrbeShield in GI-ARS

Jan. 7, 2013

Savant obtains NIDA funding for preclinical development of 18-MC

Jan. 7, 2013

Probuphine obtains FDA priority review designation for opioid dependence

Jan. 3, 2013

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 28, 2025
Roche looks to grow with sequencing by expansion tech
BioWorld MedTech
Roche Holding AG revealed plans to launch its sequencing by expansion technology next year, raising the possibility that rival Illumina Inc. could face a real run...
Clots and metastasis in cancer patients start in the lung
BioWorld MedTech
The lung and thrombosis may play a key role in cancer and metastasis progression, according to a collaborative study led by Cornell University scientists. In the...
Evo 2 AI allows genome and epigenome modeling of all life domains
BioWorld MedTech
A new version of Evo, the AI developed at the Arc Institute that can be used to design genomes as long as that of a bacterium, has been retrained with the DNA...